Lisa A. Conte serves as Executive at Jaguar Health, Inc., where they oversee executive responsibilities. Since joining the company, Lisa A. Conte has executed 8 insider transactions totaling $21.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 17, 2024 involved exercising options for 2,695 shares valued at $0.
Lisa A. Conte currently holds 7,295 shares of Jaguar Health, Inc. (JAGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lisa A. Conte has been a net buyer of JAGX stock. They have purchased $21.7K and sold $0 worth of shares.
Lisa A. Conte's most recent insider trade was on May 17, 2024, when they sold 2,695 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 600 |
| $N/A |
| Discretionary |
| Aug 14, 2023 | JAGX | $0 | Award | 383,605 | $N/A | Discretionary |
| May 17, 2023 | JAGX | $0 | Option Exercise | 2,694 | $N/A | Discretionary |
| Apr 5, 2023 | JAGX | $0 | Option Exercise | 600 | $N/A | Discretionary |
| Apr 5, 2022 | JAGX | $0 | Option Exercise | 45,000 | $N/A | Discretionary |
| Sep 13, 2021 | JAGX | $20.0K | Purchase | 7,968 | $2.51 | Discretionary |
| Jul 18, 2018 | JAGX | $1.7K | Purchase | 1,500 | $1.11 | Discretionary |